The Trump administration's argument is undercut by its imposing tariffs on countries the U.S. does not have a trade deficit ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s tariffs on imports.